Could It Be HIV? Video for GPs

Thorne Harbour Health, November 2017

‘Could it be HIV?’ features of the story of Abby Landy, whose story is all-too-common for the many individuals who are given a late HIV diagnosis.

Produced with the support of ViiV healthcare, this video encourages clinicians and doctors to ‘consider HIV’. This clip also features Professor Jenny Hoy from Alfred Health.

“This video is vital. We shouldn’t be missing opportunities to diagnose HIV. With a late diagnoses, there is already substantial damage to the immune system. Diagnosing HIV in a timely manner is paramount — for the benefit of the individual as well as the benefit of the broader community’s health and wellbeing.” – Jenny Hoy

  •  Watch embedded video below:

Updated Guidelines: Australian STI & HIV Testing Guidelines 2019 for Asymptomatic MSM

Sexually Transmissible Infections in Gay Men Action Group (STIGMA), September 2019

Most sexually transmitted infections (STIs) are asymptomatic. Testing and treatment of asymptomatic men who have sex with men (MSM) is the most effective method to interrupt transmission and reduce the burden of illness. In particular, syphilis is increasingly common, is often asymptomatic, and can cause significant morbidity.

The main barriers to STI control are insufficient frequency of testing in MSM, and incomplete testing. For example, chlamydia and gonorrhoea tests should be performed at all three sites (swab of oropharynx and anorectum, and first
pass urine), and syphilis serology should be performed every time a HIV test or HIV treatment monitoring is performed.

HIV is now a medically preventable infection. All men who are eligible under the Australian HIV Pre-Exposure guidelines should be actively offered PrEP: www.ashm.org.au/HIV/PrEP All people with HIV should be advised to commence treatment and, where possible, have an undetectable viral load.
These guidelines are intended for all MSM, including trans men who have sex with other men .

This current version is endorsed by the Australasian Society for HIV, Viral Hepatitis, and Sexual Health Medicine, Australasian Sexual Health Alliance, Australasian Chapter of Sexual Health Medicine of the Royal Australasian College of Physicians and is approved as an accepted clinical resource by the Royal Australian College of General Practitioners.

What’s new in HIV and hep C? An update for Aboriginal and Torres Strait Islander health workers

Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine (ASHM), June 2019

This Deadly Sex Update webinar provides Aboriginal and Torres Strait Islander health and community workers with an introduction and the latest news in hepatitis C and HIV.

The information presented supports health workers to discuss key messages with clients and the community around hep C and HIV, including testing, prevention, current treatments and management.

Presenter: Dr Darren Russell, Director of Cairns Sexual Health.
Presented on: Monday 10 June 2019

What’s new in HIV and hep C? An update for Aboriginal and Torres Strait Islander health workers. Dr Darren Russell, June 2019 from ASHM on Vimeo.

HIV and viral hepatitis disclosure [in South Australia] – factsheet

SA Health, updated 2019

Deciding to disclose your HIV or viral hepatitis (hepatitis B or hepatitis C) status is a personal choice. There are few situations where you are legally required to disclose your HIV or viral hepatitis status, however, there may be times when it’s in your best interests to disclose your status even if you are not legally required to do so.

 

‘Lets Talk About It’: South Australian Sexual Health Survey Results 2019

SAHMRI & Flinders University,  4th October, 2019

A South Australian-first youth sexual health survey has provided a unique snapshot of the sexual behaviours and knowledge of the state’s young people. 

The head of SAHMRI’s Sexual Health and Wellbeing program, Associate Professor James Ward, says the results will help design policies, health services and education programs aimed at reducing sexually transmitted infections (STIs), HIV and viral hepatitis (BBVs).

 

 

Striving towards the elimination of HCV infection among PWID

International Journal of Drug Policy, Volume 72,Pages 1-198 (October 2019)

Nearly 200 pages of open access articles from projects and research around the world.

While this special issue highlights some successful efforts towards HCV elimination among people who inject drugs, it also highlights the relative lack of attention to settings in which resources enabling elimination are scarce, and where elimination hopes and potentials are less clear, such as in many low and middle income countries. Strengthening capacity in areas of the world where resources are more limited will be a critical step towards ensuring equity for all so that global HCV elimination among PWID can be achieved.

  • Browse articles here
  • You can also download the full issue as PDF by creating an account and signing in at the above link